BACKGROUND: Erythropoietin (Epo) has neuroprotective and neurotrophic effects in animal models and affects cognitive and associated neural responses in humans. These effects have highlighted Epo as a candidate for treatment of psychiatric disease including schizophrenia and depression. The current study aimed to explore the effects of Epo on neural and behavioral measures of emotional processing relevant for depression and the effects of conventional antidepressant medication. METHODS: In th...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.
If you are the owner of this record, you can report an update to it here: Report update to this record